Results 181 to 190 of about 5,866 (194)

Pegfilgrastim

Reactions Weekly, 2015
openaire   +1 more source

Pegfilgrastim

Drugs, 2012
exaly  

A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial

Oncologist, 2016
Nadia Harbeck
exaly  

Pharmacokinetic/Pharmacodynamic Modeling of Pegfilgrastim in Healthy Subjects

Journal of Clinical Pharmacology, 2006
exaly  

The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies

Gynecologic Oncology, 2009
Joseph R Biggio
exaly  

Pegfilgrastim

Reactions Weekly, 2016
openaire   +2 more sources

Pharmacokinetics and Pharmacodynamics of Pegfilgrastim

Clinical Pharmacokinetics, 2012
exaly  

The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy

Annals of Oncology, 2015
exaly  

Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials

Current Medical Research and Opinion, 2007
exaly  

Formulation of Neulasta® (pegfilgrastim)

Advanced Drug Delivery Reviews, 2008
exaly